Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)

This study is currently recruiting participants.
Verified October 2012 by Fudan University
Sponsor:
Information provided by (Responsible Party):
Xichun Hu, Fudan University
ClinicalTrials.gov Identifier:
NCT01380808
First received: May 10, 2011
Last updated: October 5, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)